ZA926837B - A pharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonist - Google Patents
A pharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonistInfo
- Publication number
- ZA926837B ZA926837B ZA926837A ZA926837A ZA926837B ZA 926837 B ZA926837 B ZA 926837B ZA 926837 A ZA926837 A ZA 926837A ZA 926837 A ZA926837 A ZA 926837A ZA 926837 B ZA926837 B ZA 926837B
- Authority
- ZA
- South Africa
- Prior art keywords
- combination
- pharmaceutical composition
- uricosuric agent
- eaa antagonist
- antagonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75640191A | 1991-09-09 | 1991-09-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA926837B true ZA926837B (en) | 1994-03-08 |
Family
ID=25043303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA926837A ZA926837B (en) | 1991-09-09 | 1992-09-08 | A pharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonist |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US5407935A (de) |
| EP (1) | EP0603301B1 (de) |
| JP (1) | JP3218038B2 (de) |
| AT (1) | ATE162075T1 (de) |
| AU (1) | AU660717B2 (de) |
| CA (1) | CA2115442C (de) |
| DE (1) | DE69224069T2 (de) |
| DK (1) | DK0603301T3 (de) |
| ES (1) | ES2113957T3 (de) |
| GR (1) | GR3026369T3 (de) |
| MX (1) | MX9205127A (de) |
| NO (1) | NO307645B1 (de) |
| NZ (1) | NZ244243A (de) |
| PT (1) | PT100850B (de) |
| WO (1) | WO1993004688A1 (de) |
| ZA (1) | ZA926837B (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69224069T2 (de) * | 1991-09-09 | 1998-07-02 | Warner-Lambert Co., Ann Arbor, Mich. | Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält |
| US5318985A (en) * | 1991-12-20 | 1994-06-07 | Merrell Dow Pharmaceuticals Inc. | Potentiation of NMDA antagonists |
| US5854217A (en) | 1992-09-28 | 1998-12-29 | Bearsden Bio, Inc. | Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
| JPH07505908A (ja) * | 1992-09-28 | 1995-06-29 | マックセチーニ、マリア ルイザ | Ｎｍｄａ受容体のアロステリックモジュレーター |
| WO1998003189A1 (en) | 1996-07-22 | 1998-01-29 | Cognetix, Inc. | Use of conantokins |
| CA2261568A1 (en) | 1996-07-22 | 1998-01-29 | University Of Utah Research Foundation | Conantokins |
| US6277825B1 (en) | 1996-07-22 | 2001-08-21 | University Of Utah Research Foundation | Use of conantokins for treating pain |
| IL125950A0 (en) * | 1997-09-05 | 1999-04-11 | Pfizer Prod Inc | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
| EP1082113A2 (de) * | 1998-05-26 | 2001-03-14 | Peter Louis Carlen | Zusammensetzungen und verfahren zur verminderung von behinderter mentaler funktion, gedächtnisschwund und zur verkürzung der erholungszeit nach der narkose bei zaügetieren |
| US6399574B1 (en) | 2000-03-22 | 2002-06-04 | University Of Utah Research Foundation | Use of conantokins |
| DE60137635D1 (de) | 2000-06-28 | 2009-03-26 | Merck & Co Inc | Verwendung von allopurinol zur behandlung von bluthochdruck |
| US7276514B2 (en) * | 2002-05-15 | 2007-10-02 | Charitable Leadership Foundation - Medical Technology Acceleration Program | Pyrroloquinoline quinone drugs for treatment of cardiac injury and methods of use thereof |
| US20080051428A1 (en) * | 2002-05-15 | 2008-02-28 | Davis Paul J | Pyrroloquinoline quinone drugs and methods of use thereof |
| US20040152694A1 (en) * | 2003-02-04 | 2004-08-05 | Istvan Kurucz | Methods and compositions for treating inflammatory disorders of the airways |
| US20050209317A1 (en) * | 2004-03-22 | 2005-09-22 | Apkarian A V | Method and compositions for treatment of chronic neuropathic pain |
| US8461223B2 (en) | 2005-04-07 | 2013-06-11 | Aspen Aerogels, Inc. | Microporous polycyclopentadiene-based aerogels |
| ITFI20050083A1 (it) * | 2005-04-29 | 2006-10-30 | Univ Firenze | Uso dell'acido chinurenico per la prevenzione e il trattamento dello shock |
| WO2006121995A2 (en) | 2005-05-09 | 2006-11-16 | Tap Pharmaceutical Products, Inc. | Methods for treating nephrolithiasis |
| US9181486B2 (en) | 2006-05-25 | 2015-11-10 | Aspen Aerogels, Inc. | Aerogel compositions with enhanced performance |
| EP2338492A1 (de) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Verfahren und Zusammensetzung zur Behandlung von Alzheimer |
| RU2013109380A (ru) | 2010-09-10 | 2014-10-20 | Такеда Фармасьютикалс Ю.С.А.,Инк. | Способ сопутствующей терапии с применением теофиллина и фебуксостата |
| US10806711B2 (en) | 2011-08-12 | 2020-10-20 | University Of Cincinnati | Method of treating acute decompensated heart failure with probenecid |
| CA2904671C (en) | 2013-03-13 | 2022-08-30 | University Of Cincinnati | Treatment of a diastolic cardiac dysfunction with a trpv2 receptor agonist |
| US20170143681A1 (en) | 2015-11-02 | 2017-05-25 | Apkarian Technologies Llc | Methods and compositions for treating pain |
| EP3427729A1 (de) * | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid zur behandlung von epileptischen erkrankungen, störungen oder zuständen |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4812458A (en) * | 1986-09-16 | 1989-03-14 | A/S Ferrosan | 6,7-disubstituted-2,3-dihydroxyquinoxaline compounds, pharmaceutical compositions thereof, and their use as neuroleptics |
| DK146787A (da) * | 1987-03-23 | 1988-09-24 | Ferrosan | Heterocykliske forbindelser, deres fremstilling og anvendelse |
| DE69201141T2 (de) * | 1991-02-28 | 1995-05-11 | Merrell Dow Pharma | NMDA-Antagonisten. |
| DE69224069T2 (de) * | 1991-09-09 | 1998-07-02 | Warner-Lambert Co., Ann Arbor, Mich. | Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält |
-
1992
- 1992-09-02 DE DE69224069T patent/DE69224069T2/de not_active Expired - Fee Related
- 1992-09-02 AU AU25943/92A patent/AU660717B2/en not_active Ceased
- 1992-09-02 JP JP50544593A patent/JP3218038B2/ja not_active Expired - Fee Related
- 1992-09-02 CA CA002115442A patent/CA2115442C/en not_active Expired - Fee Related
- 1992-09-02 WO PCT/US1992/007540 patent/WO1993004688A1/en active IP Right Grant
- 1992-09-02 EP EP92919882A patent/EP0603301B1/de not_active Expired - Lifetime
- 1992-09-02 ES ES92919882T patent/ES2113957T3/es not_active Expired - Lifetime
- 1992-09-02 AT AT92919882T patent/ATE162075T1/de not_active IP Right Cessation
- 1992-09-02 DK DK92919882T patent/DK0603301T3/da active
- 1992-09-07 NZ NZ244243A patent/NZ244243A/en unknown
- 1992-09-08 ZA ZA926837A patent/ZA926837B/xx unknown
- 1992-09-08 PT PT100850A patent/PT100850B/pt not_active IP Right Cessation
- 1992-09-08 MX MX9205127A patent/MX9205127A/es not_active IP Right Cessation
-
1993
- 1993-04-19 US US08/049,228 patent/US5407935A/en not_active Expired - Fee Related
-
1994
- 1994-03-08 NO NO940809A patent/NO307645B1/no not_active IP Right Cessation
-
1995
- 1995-10-05 US US08/539,398 patent/US5627168A/en not_active Expired - Fee Related
-
1996
- 1996-12-31 US US08/775,637 patent/US5767119A/en not_active Expired - Fee Related
-
1998
- 1998-03-13 GR GR980400554T patent/GR3026369T3/el unknown
- 1998-03-27 US US09/049,495 patent/US5942513A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| GR3026369T3 (en) | 1998-06-30 |
| AU660717B2 (en) | 1995-07-06 |
| AU2594392A (en) | 1993-04-05 |
| ES2113957T3 (es) | 1998-05-16 |
| NO307645B1 (no) | 2000-05-08 |
| US5627168A (en) | 1997-05-06 |
| CA2115442C (en) | 2003-09-23 |
| PT100850B (pt) | 1999-07-30 |
| CA2115442A1 (en) | 1993-03-18 |
| ATE162075T1 (de) | 1998-01-15 |
| WO1993004688A1 (en) | 1993-03-18 |
| JP3218038B2 (ja) | 2001-10-15 |
| NZ244243A (en) | 1995-07-26 |
| NO940809D0 (no) | 1994-03-08 |
| US5407935A (en) | 1995-04-18 |
| DE69224069D1 (de) | 1998-02-19 |
| JPH06510544A (ja) | 1994-11-24 |
| DK0603301T3 (da) | 1998-09-14 |
| PT100850A (pt) | 1993-10-29 |
| US5767119A (en) | 1998-06-16 |
| US5942513A (en) | 1999-08-24 |
| NO940809L (no) | 1994-03-08 |
| EP0603301A1 (de) | 1994-06-29 |
| MX9205127A (es) | 1993-07-01 |
| DE69224069T2 (de) | 1998-07-02 |
| EP0603301B1 (de) | 1998-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA926837B (en) | A pharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonist | |
| PT932402E (pt) | Metodo de utilizacao de inibidores de ciclooxigenase-2 no tratamento e prevencaode neoplasia | |
| PT705100E (pt) | Guanidinas substituidas terapeuticas | |
| EA200100572A1 (ru) | Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии | |
| UA48946C2 (uk) | Арилалкілдіазинони, спосіб їх одержання (варіанти), фармацевтичний склад, спосіб його одержання та спосіб лікування | |
| UA26213C2 (uk) | Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові | |
| FI941826A (fi) | Menetelmät ja koostumukset elimen hypofunktion ennaltaehkäisemiseksi ja/tai terapeuttiseksi hoitamiseksi | |
| MX9602818A (es) | Un metodo de tratamiento de infeccion parasitaria usando antagonistas ige. | |
| UA41355C2 (uk) | Засіб для лікування нейро-сніду | |
| RU94020410A (ru) | Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений | |
| ITMI931649A1 (it) | Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico | |
| ATE38036T1 (de) | Benzothiophenderivate als bronchodilatoren. | |
| MXPA94009086A (es) | Guanidinas sustituidas terapeuticas. | |
| EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
| ATE180669T1 (de) | Verwendung von pregnanderivaten zur behandlung von tumoren | |
| NO993627L (no) | Anvendelse av en forbindelse for fremstilling av et legemiddel | |
| TR199801801T2 (xx) | Madde k�t�ye kullan�m�n�n tedavisi. | |
| EA199600048A3 (ru) | N,n-диэтил-8,8-дипропил-2-азаспиро[4,5]декан-2-пропанамин дималеат, фармацевтическая композиция на его основе и способ индуцирования иммуномодуляции | |
| HUP9903685A2 (hu) | Olanzapin alkalmazása túlzott agresszivitás kezelésére szolgáló gyógyszerkészítmények előállítására | |
| ATE254919T1 (de) | Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8 | |
| EP0796105A4 (de) | Pharmazeutische zusammensetzung zur behandlung von autoimmun krankheiten mit dem b-oligomer des pertussis toxin oder untereinheiten davon | |
| DE69429538D1 (de) | Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen | |
| RU93035807A (ru) | Способ лечения юношеского эпифизиолиса | |
| DK8893D0 (da) | Medicament for treatment or prevention of disease |